ArticleTherapeutic advances in chronic disease2023

Comparison of the profiles of first-line PD-1/PD-L1 inhibitors for advanced NSCLC lacking driver gene mutations: a systematic review and Bayesian network meta-analysis.

Fu Wenfan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.